Nov 18 |
How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
|
Nov 18 |
Lilly, Incyclix to work on Verzenio combo treatment for breast cancer
|
Nov 18 |
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
|
Nov 18 |
Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
|
Nov 18 |
Eli Lilly’s tirzepatide cuts risk of worsening heart failure in HFpEF, obese patients
|
Nov 18 |
Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
|
Nov 18 |
Eli Lilly follows J&J in suing Biden administration over 340B rebates
|
Nov 18 |
Eli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF
|
Nov 17 |
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own Now
|
Nov 17 |
Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth
|